Phospho-ILK (Ser246) Antibody

What is the biological significance of ILK phosphorylation at Ser246?

The phosphorylation of ILK at Ser246 represents a critical regulatory mechanism that governs its function in cellular signaling. This specific phosphorylation is carried out by serum- and glucocorticoid-induced kinase 1 (SGK1) and is essential for forming a protein-protein complex with 14-3-3 proteins . This interaction influences downstream signal transduction pathways and cellular processes. ILK's phosphorylation status affects its association with the cytoplasmic domain of beta integrins at the cell membrane, where it regulates integrin-mediated signaling . The modification at Ser246 can alter ILK's ability to interact with other binding partners, potentially affecting its role in epithelial-mesenchymal transition, tumor growth, and metastasis .

How does Phospho-ILK (Ser246) antibody specificity compare to other ILK antibodies?

Phospho-ILK (Ser246) antibodies are specifically designed to detect ILK only when phosphorylated at the Ser246 residue, providing a significant advantage for studying this specific post-translational modification . Unlike general ILK antibodies that recognize total ILK protein regardless of phosphorylation status, these phospho-specific antibodies allow researchers to monitor dynamic changes in ILK phosphorylation in response to various stimuli.

When evaluating specificity, researchers should note that most commercially available antibodies are raised against synthesized peptides derived from human ILK surrounding the Ser246 phosphorylation site (typically amino acids 212-261) . The specificity of these antibodies can be validated using blocking peptides that prevent antibody binding to the target epitope. This comparison with blocked antibody staining helps distinguish between specific and non-specific signals, particularly important in Western blotting and immunohistochemistry applications .

Which experimental controls are essential when using Phospho-ILK (Ser246) antibodies?

For rigorous experimental design with Phospho-ILK (Ser246) antibodies, several controls are indispensable:

• Blocking peptide controls: Using the phosphorylated peptide that corresponds to the immunogen to block antibody binding is crucial for validating signal specificity . Side-by-side comparison of staining patterns with and without blocking peptide helps identify true positive signals.

• Positive tissue controls: Human brain tissue is recommended as a positive control for immunohistochemistry applications, as it shows reliable phospho-ILK (Ser246) expression .

• Phosphatase treatment controls: Samples treated with phosphatases to remove phosphate groups should show reduced or absent signal compared to untreated samples, confirming phospho-specificity.

• Cross-reactivity controls: When working with non-human samples, sequence homology analysis should be performed to ensure the antibody will recognize the conserved phosphorylation site.

These controls collectively ensure the reliability and specificity of experimental results, particularly important given the potential for cross-reactivity with other phosphorylated proteins or non-phosphorylated ILK.

How can researchers differentiate between ILK isoforms when using Phospho-ILK (Ser246) antibodies?

Distinguishing between ILK isoforms presents a significant challenge that requires careful experimental design. Current research reveals three ILK isoforms (ILK1, ILK2, and ILK3) with distinct structures and potentially different functions . When using Phospho-ILK (Ser246) antibodies, researchers must consider that:

Most antibodies are developed against the sequence surrounding Ser246 in ILK1, potentially creating detection bias. For example, antibodies directed against the N-terminus of ILK1 won't detect ILK3, while those recognizing the central region may have variable affinity for different isoforms . Consider this example: an antibody directed against residues 118-241 of ILK1 would overlap significantly with ILK3 (86% of the immunogen) but minimally with ILK2 (only 29% overlap) .

To differentiate between isoforms:

• Perform Western blotting with control lysates expressing only one isoform

• Use isoform-specific primers for RT-PCR validation

• Consider complementary techniques like mass spectrometry

• Express tagged versions of specific isoforms to verify antibody reactivity

What are the methodological considerations for studying ILK phosphorylation dynamics in live cells?

Investigating the temporal and spatial dynamics of ILK phosphorylation at Ser246 in living cells requires sophisticated methodological approaches:

Real-time phosphorylation monitoring techniques:

• Phospho-FRET biosensors: Design intramolecular FRET-based sensors incorporating the ILK region containing Ser246 between fluorescent protein pairs

• Phospho-specific nanobodies: Develop cell-permeable nanobodies that specifically recognize Phospho-ILK (Ser246)

• Temporal control: Use complementary techniques like phospho-flow cytometry to capture population-level dynamics at different timepoints

Experimental design considerations:

• Maintain physiological conditions during imaging to prevent artifacts

• Include positive controls using SGK1 activators, as SGK1 phosphorylates ILK at Ser246

• Design kinetic experiments to capture both rapid and sustained phosphorylation events

• Consider subcellular compartmentalization when interpreting results

How does the phosphorylation of ILK at Ser246 influence its interaction with binding partners?

The phosphorylation of ILK at Ser246 dramatically alters its interactome, with significant functional implications. Research demonstrates that this modification is essential for forming protein-protein complexes with 14-3-3 proteins . This interaction represents a critical regulatory mechanism that influences downstream signaling pathways.

Key interactions affected by Ser246 phosphorylation:

To study these interactions experimentally:

• Use co-immunoprecipitation with phospho-specific antibodies

• Create phosphomimetic (S246D/E) and phospho-deficient (S246A) mutants

• Employ proximity ligation assays to visualize interactions in situ

• Perform comparative proteomic analysis of wild-type vs. mutant interactomes

Understanding these phosphorylation-dependent interactions provides insight into how post-translational modifications regulate ILK's role in cellular processes including epithelial-mesenchymal transition and tumor progression .

What strategies can resolve inconsistent staining patterns when using Phospho-ILK (Ser246) antibodies in immunohistochemistry?

Inconsistent immunohistochemical staining with Phospho-ILK (Ser246) antibodies can stem from multiple technical and biological variables. A systematic troubleshooting approach includes:

Sample preparation optimization:

• Fixation parameters: Overfixation can mask epitopes while underfixation causes tissue degradation

• Antigen retrieval: Test both heat-induced epitope retrieval (citrate buffer pH 6.0) and enzymatic methods

• Blocking protocol: Optimize blocking reagents to reduce background without compromising signal

Antibody validation strategies:

• Peptide competition: Compare staining with and without blocking peptide to confirm specificity

• Multiple antibody comparison: Use antibodies from different sources targeting the same epitope

• Phosphatase treatment: Treat sections with lambda phosphatase to verify phospho-specificity

When human brain tissue is used as recommended positive control , establish consistent staining patterns before proceeding with experimental samples. For optimal results, maintain consistent antibody dilutions (typically 1:100-1:300 for IHC applications) and standardize incubation conditions across experiments.

Researchers should also consider the biological variability in phosphorylation status, as rapid dephosphorylation can occur during tissue processing. Implement phosphatase inhibitors throughout the procedure to preserve physiological phosphorylation levels.

How can researchers quantitatively assess phosphorylation levels at Ser246 in complex biological samples?

Quantitative assessment of ILK Ser246 phosphorylation requires robust analytical approaches that account for sample complexity and phosphorylation dynamics:

Quantitative methodologies:

• Phospho-specific ELISA:

  • Develop sandwich ELISA using capture antibodies against total ILK and detection with Phospho-ILK (Ser246) antibodies

  • Create standard curves using recombinant phosphorylated ILK

  • Optimal working dilutions of approximately 1:5000 for ELISA applications

• Quantitative immunoblotting:

  • Normalize phospho-signal to total ILK protein

  • Use fluorescently-labeled secondary antibodies for wider dynamic range

  • Include calibration standards for absolute quantification

• Mass spectrometry-based approaches:

  • Employ targeted phosphoproteomic methods focusing on Ser246-containing peptides

  • Use AQUA peptides (isotopically labeled standards) for absolute quantification

  • Consider parallel reaction monitoring for enhanced sensitivity

• Microscopy-based quantification:

  • Apply digital image analysis to IHC sections

  • Establish signal intensity thresholds based on controls

  • Quantify positive cell percentages and staining intensity distribution

For all methodologies, rigorous validation is essential using positive controls (SGK1-activated samples) and negative controls (phosphatase-treated samples or phospho-deficient mutants). Researchers should also account for potentially different phosphorylation patterns across ILK isoforms when interpreting quantitative data .

What are the critical variables affecting antibody performance when detecting phosphorylated ILK?

Multiple variables can significantly impact the performance of Phospho-ILK (Ser246) antibodies, requiring careful optimization:

Storage and handling factors:

• Temperature stability: Maintain antibody at recommended storage conditions (-20°C long-term, 4°C short-term)

• Freeze-thaw cycles: Minimize repeated freezing and thawing which can degrade antibody performance

• Buffer composition: The presence of 50% glycerol, 0.5% BSA, and 0.02% sodium azide helps maintain antibody stability

Sample-related variables:

• Phosphatase activity: Endogenous phosphatases can rapidly dephosphorylate ILK during sample preparation

• Fixation methods: Different fixatives can differentially affect epitope accessibility

• Protein denaturation conditions: Critical for exposing the phospho-epitope in techniques like Western blotting

Experimental conditions:

• pH sensitivity: Optimal buffer pH is crucial for antibody-epitope interaction

• Incubation time and temperature: Affect binding kinetics and signal-to-noise ratio

• Blocking reagents: Can interfere with phospho-specific binding sites

When optimizing protocols, researchers should systematically test these variables using appropriate controls. For example, when performing IHC, comparing staining patterns with and without blocking peptide helps establish specificity parameters . Additionally, understanding the molecular context of the Ser246 residue (sequence: IFSHP) helps anticipate potential cross-reactivity with similar phosphorylation motifs.

How is the role of ILK Ser246 phosphorylation being integrated into current models of cancer progression?

Recent investigations into ILK Ser246 phosphorylation have begun reshaping our understanding of cancer progression mechanisms. Given that ILK overexpression is implicated in tumor growth and metastasis , the specific role of Ser246 phosphorylation represents an important regulatory node.

Current research indicates that the phosphorylation of ILK at Ser246 by SGK1 creates binding sites for 14-3-3 proteins , potentially affecting downstream signaling cascades relevant to cancer progression. This phosphorylation event may modify ILK's function in epithelial-mesenchymal transition (EMT), a critical process in cancer metastasis .

Emerging models suggest several mechanisms through which Ser246 phosphorylation may influence cancer:

• Modulation of cell adhesion properties through altered integrin signaling

• Regulation of cancer stem cell properties via modified Wnt signaling

• Control of cellular migration through effects on focal adhesion dynamics

• Influence on therapeutic resistance mechanisms

Future investigations should focus on developing phosphorylation-state specific interventions that could selectively target cancer cells with aberrant ILK phosphorylation patterns. The continued development and application of highly specific Phospho-ILK (Ser246) antibodies will remain essential for advancing this research frontier.

What emerging technologies are enhancing the study of phosphorylation dynamics at Ser246?

Cutting-edge technologies are transforming our ability to study the dynamic phosphorylation of ILK at Ser246:

Advanced imaging technologies:

• Super-resolution microscopy: Techniques like STORM and PALM enable visualization of phosphorylation events at nanometer resolution

• Lattice light-sheet microscopy: Allows for long-term imaging of phosphorylation dynamics with reduced phototoxicity

• Expansion microscopy: Physical enlargement of samples improves resolution of phosphorylation-dependent protein complexes

Single-cell analytical approaches:

• Mass cytometry (CyTOF): Enables multi-parameter analysis of phosphorylation states at single-cell resolution

• Single-cell phosphoproteomics: Reveals cell-to-cell variability in Ser246 phosphorylation levels

• Spatial transcriptomics combined with phospho-protein detection: Correlates phosphorylation status with gene expression patterns

Genetic and protein engineering methods:

• CRISPR-based phosphorylation reporters: Allows endogenous tagging of ILK for phosphorylation monitoring

• Optogenetic control of kinases/phosphatases: Enables precise temporal control of Ser246 phosphorylation

• Bioluminescence resonance energy transfer (BRET) sensors: Monitors phosphorylation-dependent protein interactions in real-time

These emerging technologies complement traditional approaches using Phospho-ILK (Ser246) antibodies , providing unprecedented insights into the temporal and spatial dynamics of ILK phosphorylation.

How do contradictory findings about ILK kinase activity influence interpretation of Ser246 phosphorylation data?

The controversial nature of ILK's kinase activity significantly impacts how researchers interpret Ser246 phosphorylation data. There has been ongoing debate about whether ILK functions as a true kinase or a pseudokinase, with evidence supporting both perspectives .

Implications for experimental design and interpretation:

• Phosphorylation mechanism uncertainty:

  • If ILK is a pseudokinase, Ser246 phosphorylation must be catalyzed exclusively by other kinases like SGK1

  • If ILK possesses kinase activity, potential auto-phosphorylation at Ser246 must be considered

• Functional consequences of phosphorylation:

  • In the pseudokinase model, Ser246 phosphorylation likely serves primarily as a scaffold modification affecting protein-protein interactions

  • In the kinase model, Ser246 phosphorylation could potentially regulate catalytic activity

• Experimental approach considerations:

  • Researchers investigating kinase-dependent functions should include kinase-dead ILK mutants as controls

  • Studies of scaffold functions should focus on phosphorylation-dependent protein interactions

The current literature suggests that regardless of ILK's intrinsic kinase capabilities, Ser246 phosphorylation by SGK1 is critical for 14-3-3 protein binding and subsequent signaling events . Researchers should design experiments acknowledging these conflicting models, ideally including controls that can distinguish between scaffold-dependent and kinase-dependent functions of phosphorylated ILK.